Document:

Exhibit
4.7

 

SIGNING
DEBENTURE

 

NEITHER
THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES
ARE RESTRICTED AND MAY NOT BE OFFERED, RESOLD, PLEDGED OR TRANSFERRED EXCEPT AS PERMITTED UNDER THE ACT PURSUANT TO REGISTRATION
REQUIREMENTS THEREOF OR EXEMPTION THEREFROM.

 

NANOFLEX
POWER CORPORATION 

 

CONVERTIBLE
DEBENTURE DUE JUNE 19, 2021

 

	Issuance
    Date: June 19, 2018	Principal
    Amount: $75,000.00

 

FOR
VALUE RECEIVED, NANOFLEX POWER CORPORATION, a corporation organized and existing under the laws of the State of Florida (the
“Company”), hereby promises to pay to PEAK ONE OPPORTUNITY FUND, L.P., having its address at 333 South Hibiscus
Drive, Miami Beach, FL 33139, or its assigns (the “Holder” and together with the other holders of Debentures issued
pursuant to the Securities Purchase Agreement (as defined below), the “Holders”), the initial principal sum of Seventy
Five Thousand and 00/100 Dollars ($75,000.00) (subject to adjustment as provided herein, the “Principal Amount”) on
June 19, 2021 (the “Maturity Date”). The Company has the option to redeem this Debenture prior to the Maturity Date
pursuant to Section 2(b). All unpaid principal due and payable on the Maturity Date shall be paid in the form of Common Stock
of the Company, par value $0.0001 per share (“Common Stock”) pursuant to Section 3 or in cash pursuant to the terms
of this Debenture. The Holder has the option to cause any outstanding principal and accrued interest, if any, on this Debenture
to be converted into Common Stock at any time prior to the Redemption Date (as defined below) or the Maturity Date pursuant to
Section 2(a).

 

This
Debenture is one of the Debentures referred to in the Securities Purchase Agreement (the “Securities Purchase Agreement”)
dated as of June 13, 2018, between the Company and the Holder. Capitalized terms used but not defined herein shall have the meanings
set forth in the Securities Purchase Agreement. This Debenture is subject to the provisions of the Securities Purchase Agreement
and further is subject to the following additional provisions:

 

1.
This Debenture has been issued subject to investment representations of the original purchaser hereof and may be transferred
or exchanged only in compliance with the Securities Act and other applicable state and foreign securities laws. The Holder
may transfer or assign this Debenture (or any part thereof) without the prior consent of the Company, and the Company shall
cooperate with any such transfer. In the event of any proposed transfer of this Debenture, the Company may require, prior to
issuance of a new Debenture in the name of such other Person, that it receive reasonable transfer documentation including
legal opinions that the issuance of the Debenture in such other name does not and will not cause a violation of the
Securities Act or any applicable state or foreign securities laws or is exempt from the registration requirements of the
Securities Act. Prior to due presentment for transfer of this Debenture to which the Company has consented, the Company and
any agent of the Company may treat the Person in whose name this Debenture is duly registered on the Company's books and
records of outstanding debt securities and obligations (“Debenture Register”) as the owner hereof for the purpose
of receiving payment as herein provided and for all other purposes, whether or not this Debenture be overdue, and neither the
Company nor any such agent shall be affected by notice to the contrary.

 

     

     

    

 

2.
Conversion at Holder’s Option; Redemption at Company’s Option.

 

a.
The Holder is entitled to, at any time or from time to time, convert the Conversion Amount (as defined below) into Conversion
Shares, at a conversion price for each share of Common Stock (the “Conversion Price”) equal to either: (i) if no Event
of Default (as defined herein) has occurred and the date of conversion is prior to the date that is one hundred eighty (180) days
after the Issuance Date, $0.25, or (ii) if an Event of Default has occurred or the date of conversion is on or after the date
that is one hundred eighty (180) days after the Issuance Date, the lesser of (a) $0.25 or (b) Sixty percent (60%) of the lowest
traded price (as reported by Bloomberg LP) of the Common Stock for the twenty (20) Trading Days immediately preceding the date
of the date of conversion of the Debentures (provided, further, that if either the Company is not DWAC Operational at the time
of conversion or the Common Stock is traded on the OTC Pink (“OTCP”) at the time of conversion, then Sixty percent
(60%) shall automatically adjust to Fifty percent (50%) of the lowest traded price (as reported by Bloomberg LP) of the Common
Stock for the twenty (20) Trading Days immediately preceding the date of conversion of the Debentures), subject in each case to
equitable adjustments resulting from any stock splits, stock dividends, recapitalizations or similar events. The Company shall
issue irrevocable instructions to its Transfer Agent regarding conversions such that the transfer agent shall be authorized and
instructed to issue Conversion Shares upon its receipt of a Notice of Conversion without further approval or authorization from
the Company. For purposes of this Debenture, the “Conversion Amount” shall mean the sum of (A) all or any portion
of the outstanding Principal Amount of this Debenture, as designated by the Holder upon exercise of its right of conversion plus
(B) any interest, pursuant to Section 10 or otherwise, that has accrued on the portion of the Principal Amount that has been designated
for payment pursuant to (A).

 

Conversion
shall be effectuated by delivering by facsimile, email or other delivery method to the Transfer Agent of the completed form
of conversion notice attached hereto as Annex A (the “Notice of Conversion”), executed by the Holder of
the Debenture evidencing such Holder's intention to convert this Debenture or a specified portion hereof. No fractional
shares of Common Stock or scrip representing fractions of shares will be issued on conversion, but the number of shares
issuable shall be rounded to the nearest whole share. The Holder may, at its election, deliver a Notice of Conversion to
either the Company or the Transfer Agent. The date on which notice of conversion is given (the “Conversion Date”)
shall be deemed to be the date on which the Company or the Transfer Agent, as the case may be, receives by fax, email or
other means of delivery used by the Holder the Notice of Conversion (such receipt being evidenced by electronic confirmation
of delivery by facsimile or email or confirmation of delivery by such other delivery method used by the Holder). Delivery of
a Notice of Conversion to the Transfer Agent may be given by the Holder by facsimile, or by delivery to the Transfer Agent at
the address set forth in the Transfer Agent Instruction Letter (or such other contact facsimile number, email or street
address as may be designated by the Transfer Agent to the Holder). Delivery of a Notice of Conversion to the Company shall be
given by the Holder pursuant to the notice provisions set forth in Section 10 of the Agreement. The Conversion Shares must be
delivered to the Holder within two (2) business days from the date of delivery of the Notice of Conversion to the Transfer
Agent or Company, as the case may be. Conversion shares shall be delivered by DWAC so long as the Company is then DWAC
Operational, unless the Holder expressly requests delivery in certificated form or the Conversion Shares are in the form of
Restricted Stock and are required to bear a restrictive legended. Conversion Shares shall be deemed delivered (i) if
delivered by DWAC, upon deposit into the Holder’s brokerage account, or (ii) if delivered in certificated form, upon
the Holder’s actual receipt of the Conversion Shares in certificated form at the address specified by the Holder in the
Notice of Conversion, as confirmed by written receipt. All expenses incurred by Holder, for the issuance and clearing of the
Common Stock into which this Debenture is convertible into, shall immediately and automatically be added to the balance
of the Debenture at such time as the expenses are incurred by Holder.

 

    	 	2	 

     

    

 

If
at any time the Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock,
then at the sole discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the
Conversion Amount for such conversion may be increased to include Additional Principal, where “Additional Principal”
means such additional amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares
issuable upon such conversion to equal the same number of conversion shares as would have been issued had the Conversion Price
not been adjusted by the Holder to the par value price.

 

Notwithstanding
the foregoing, unless the Holder delivers to the Company written notice at least sixty-one (61) days prior to the effective date
of such notice that the provisions of this paragraph (the “Limitation on Ownership”) shall be adjusted to 9.99% with
respect to the Holder, in no event shall a holder of Debentures have the right to convert Debentures into, nor shall the Company
issue to such Holder, shares of Common Stock to the extent that such conversion would result in the Holder and its affiliates
together beneficially owning more than 4.99% of the then issued and outstanding shares of Common Stock. For purposes hereof, beneficial
ownership shall be determined in accordance with Section 13(d) of the Exchange Act and Regulation 13D-G under the Exchange Act.

 

b.
So long as no Event of Default (as defined in Section 10) shall have occurred and be continuing (whether such Event of
Default has been declared by the Holder) (unless the Holder consents to such redemption notwithstanding such Event of
Default, as described in clause (v), below), the Company may at its option call for redemption all or part of the Debentures,
with the exception of any portion thereof which is the subject of a previously-delivered Notice of Conversion, prior to the
Maturity Date, as follows:

 

(i)
The Debentures called for redemption shall be redeemable by the Company, upon not more than two (2) days written notice, for
an amount (the “Redemption Price”) equal to: (i) if the Redemption Date (as defined below) is ninety (90) days or
less from the date of issuance of this Debenture, One Hundred Ten percent (110%) of the sum of the Principal Amount so
redeemed plus accrued interest, if any; (ii) if the Redemption Date is greater than or equal to one ninety-one (91) days from
the date of issuance of this Debenture and less than or equal to one hundred twenty (120) days from the date of issuance of
this Debenture, One Hundred Twenty percent (120%) of the sum of the Principal Amount so redeemed plus accrued interest, if
any; (iii) if the Redemption Date is greater than or equal to one hundred twenty one (121) days from the date of issuance of
this Debenture and less than or equal to one hundred eighty (180) days from the date of issuance of this Debenture, One
Hundred Thirty percent (130%) of the sum of the Principal Amount so redeemed plus accrued interest, if any; and (iv) if
either (1) the Debentures are in default but the Holder consents to the redemption notwithstanding such default or (2) the
Redemption Date is greater than or equal to one hundred eighty one (181) days from the date of issuance of this Debenture,
One Hundred Forty percent (140%) of the sum of the Principal Amount so redeemed plus accrued interest, if any. The date upon
which the Debentures are redeemed and paid shall be referred to as the “Redemption Date” (and, in the case of
multiple redemptions of less than the entire outstanding Principal Amount, each such date shall be a Redemption Date with
respect to the corresponding redemption).

 

    	 	3	 

     

    

 

(ii)
If fewer than all outstanding Debentures are to be redeemed and are held by different investors, then all Debentures shall be
partially redeemed on a pro rata basis.

 

(iii)
[Reserved]

 

(iv)
On the Redemption Date, the Company shall cause the Holders whose Debentures have been presented for redemption to be issued payment
of the Redemption Price. In the case of a partial redemption, the Company shall also issue new Debentures to the Holders for the
Principal Amount remaining outstanding after the Redemption Date promptly after the Holders’ presentation of the Debentures
called for redemption.

 

(v)
To effect a redemption the Company shall provide a written notice to the Holder(s) not more than two (2) days prior to the Redemption
Date (the “Redemption Notice”), setting forth the following:

 

		1.	the
Redemption Date;

		 	 

		2.	the
Redemption Price;

		 	 

		3.	the
aggregate Principal Amount of the Debentures being called for redemption;

		 	 

		4.	a
statement instructing the Holders to surrender their Debentures for redemption and payment of the Redemption Price, including
the name and address of the Company or, if applicable, the paying agent of the Company, where Debentures are to be surrendered
for redemption;

		 	 

		5.	a
statement advising the Holders that the Debentures (or, in the case of a partial redemption, that portion of the Principal Amount
being called for redemption) as of the Redemption Date will cease to be convertible into Common Stock as of the Redemption Date;
and

		 	 

		6.	in
the case of a partial redemption, a statement advising the Holders that after the Redemption Date a substitute Debenture will
be issued by the Company after deduction the portion thereof called for redemption, at no cost to the Holder, if the Holder so
requests.

 

    	 	4	 

     

    

 

Notwithstanding
the foregoing, in the event the Company issues a Redemption Notice but fails to fund the redemption on the Redemption Date, then
such Redemption Notice shall be null and void, and (i) the Holder(s) shall be entitled to convert the Debentures previously the
subject of the Redemption Notice, and (ii) the Company may not redeem such Debentures for at least thirty (30) days following
the intended Redemption Date that was voided, and the Company shall be required to pay to the Holder(s) the Redemption Price simultaneously
with the issuance of a Redemption Notice in connection with any subsequent redemption pursued by the Company.

 

3.
Unless demand has otherwise been made by the Holder in writing for payment in cash as provided hereunder, and so long as no Event
of Default shall exist (whether or not notice thereof has been delivered by the Holder to the Company), any Debentures not previously
tendered to the Company for conversion as of the Maturity Date shall be deemed to have been surrendered for conversion, without
further action of any kind by the Company or any of its agents, employees or representatives, as of the Maturity Date at the Conversion
Price applicable on the Maturity Date (“Mandatory Conversion”).

 

4.
No provision of this Debenture shall alter or impair the obligation of the Company, which is absolute and unconditional to convert
this Debenture into Common Stock, at the time, place, and rate herein prescribed. This Debenture is a direct obligation of the
Company.

 

5.
If the Company (a) merges or consolidates with another corporation or business entity and the Company is not the surviving entity
or (b) sells or transfers all or substantially all of its assets to another Person and the holders of the Common Stock are entitled
to receive stock, securities or property in respect of or in exchange for Common Stock, then as a condition of such merger, consolidation,
sale or transfer, the Company and any such successor, purchaser or transferee will agree that this Debenture may thereafter be
converted on the terms and subject to the conditions set forth above into the kind and amount of stock, securities or property
receivable upon such merger, consolidation, sale or transfer by a holder of the number of shares of Common Stock into which this
Debenture might have been converted immediately before such merger, consolidation, sale or transfer, subject to adjustments which
shall be as nearly equivalent as may be practicable. In the event of any (i) proposed merger or consolidation where the Company
is not the surviving entity or (ii) sale or transfer of all or substantially all of the assets of the Company (in either such
case, a “Sale”), the Holder shall have the right to convert by delivering a Notice of Conversion to the Company within
fifteen (15) days of receipt of notice of such Sale from the Company.

 

    	 	5	 

     

    

 

6.
If, at any time while any portion of this Debenture remains outstanding, the Company effectuates a stock split or reverse
stock split of its Common Stock or issues a dividend on its Common Stock consisting of shares of Common Stock or otherwise
recapitalizes its Common Stock, the Conversion Price shall be equitably adjusted to reflect such action. By way of
illustration, and not in limitation, of the foregoing (i) if the Company effectuates a 2:1 split of its Common Stock,
thereafter, with respect to any conversion for which the Company issues the shares after the record date of such split, the
Conversion Price shall be deemed to be one-half of what it had been calculated to be immediately prior to such split; (ii) if
the Company effectuates a 1:10 reverse split of its Common Stock, thereafter, with respect to any conversion for which the
Company issues the shares after the record date of such reverse split, the Conversion Price shall be deemed to be the amount
of such Conversion Price calculated immediately prior to the record date multiplied by 10; and (iii) if the Company declares
a stock dividend of one share of Common Stock for every 10 shares outstanding, thereafter, with respect to any conversion for
which the Company issues the shares after the record date of such dividend, the Conversion Price shall be deemed to be the
amount of such Conversion Price calculated immediately prior to such record date multiplied by a fraction, of which the
numerator is the number of shares for which a dividend share will be issued and the denominator is such number of shares plus
the dividend share(s) issuable or issued thereon.

 

7.
All payments contemplated hereby to be made “in cash” shall be made by wire transfer of immediately available funds
in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private
debts. All payments of cash and each delivery of shares of Common Stock issuable to the Holder as contemplated hereby shall be
made to the Holder to an account designated by the Holder to the Company and if the Holder has not designated any such accounts
at the address last appearing on the Debenture Register of the Company as designated in writing by the Holder from time to time;
except that the Holder may designate, by notice to the Company, a different delivery address for any one or more specific payments
or deliveries.

 

8.
The Holder of the Debenture, by acceptance hereof, agrees that this Debenture is being acquired for investment and that such Holder
will not offer, sell or otherwise dispose of this Debenture or the Shares of Common Stock issuable upon conversion thereof except
in compliance with the terms of the Securities Purchase Agreement and under circumstances which will not result in a violation
of the Securities Act or any applicable state Blue Sky or foreign laws or similar laws relating to the sale of securities.

 

9.
This Debenture shall be governed by and construed in accordance with the laws of the State of Nevada. Each of the parties consents
to the exclusive jurisdiction and venue of the state and/or federal courts located in Miami-Dade County, Florida in connection
with any dispute arising under this Agreement, and each waives any objection based on forum non conveniens. This provision is
intended to be a “mandatory” forum selection clause and governed by and interpreted consistent with Florida law (Nevada
law governing all other, substantive matters). Each of the parties hereby consents to the exclusive jurisdiction and venue of
any state or federal court having its situs in Miami-Dade County, Florida, and each waives any objection based on forum non conveniens.
To the extent determined by such court, the Company shall reimburse the Holder for any reasonable legal fees and disbursements
incurred by the Holder in enforcement of or protection of any of its rights under this Debenture or the Securities Purchase Agreement.

 

10.
The following shall constitute an “Event of Default”:

 

a.
The Company fails in the payment of principal or interest (to the extent that interest is imposed under this Section 10)
on this Debenture as required to be paid in cash hereunder, and payment shall not have been made for a period of five (5) business
days following the payment due date (as to which no further cure period shall apply); or

 

    	 	6	 

     

    

 

b.
Any of the representations or warranties made by the Company herein, in the Securities Purchase Agreement or in any certificate
or financial or other written statements heretofore or hereafter furnished by the Company to the Holder in connection with the
issuance of this Debenture, shall be false or misleading (including without limitation by way of the misstatement of a material
fact or the omission of a material fact) in any material respect at the time made (as to which no cure period shall apply); or

 

c.
The Company fails to remain listed on OTCP, OTCQB, or OTCQX, or a more senior stock exchange any time from the date hereof to
the Maturity Date for a period in excess of five (5) Trading Days (as to which no further cure period shall apply); or

 

d.
The Company (i) fails to timely file required SEC reports when due (including extensions), becomes, is deemed to be or asserts
that it is a “shell company” at any time for purposes of the 1933 Act, and Rule 144 promulgated thereunder or otherwise
takes any action, or refrains from taking any action, the result of which makes Rule 144 under the 1933 unavailable to the Holder
for the sale of their Securities, (ii) fails to issue shares of Common Stock to the Holder or to cause its Transfer Agent to issue
shares of Common Stock upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this
Debenture, (iii) fails to transfer or to cause its Transfer Agent to transfer any certificate for shares of Common Stock issued
to the Holder upon conversion of this Debenture as and when required by this Debenture and such transfer is otherwise lawful,
(iv) fails to remove any restrictive legend or to cause its Transfer Agent to transfer any certificate or any shares of Common
Stock issued to the Holder upon conversion of this Debenture as and when required by the relevant Transaction Document(s) and
such legend removal is otherwise lawful, or (v) the Company fails to perform or observe any of its obligations under the Section
5 of the Agreement or under the Transfer Agent Instruction Letter (no cure period shall apply in the case of clauses (i) through
(v) above, inclusive); or

 

e.
The Company fails to perform or observe, in any material respect (i) any other covenant, term, provision, condition, agreement
or obligation set forth in the Debenture, (subject to a cure period of three (3) days other than in the case of a failure under
Section 5 hereof, as to which no cure period shall apply), or (ii) any other covenant, term, provision, condition, agreement or
obligation of the Company set forth in the Securities Purchase Agreement and such failure shall continue uncured for a period
of either (1) three (3) days after the occurrence of the Company’s failure under Section 4(d), (e) (except as described
in Section 10(c) hereof, as to which Section 10(c) hereof shall control), (f), (g) or (h) of the Securities Purchase Agreement,
or (2) ten (10) days after the occurrence of the Company’s failure under any other provision of the Securities Purchase
Agreement not otherwise specifically addressed in the Events of Default set forth in this Section 10; or

 

f.
The Company shall (1) admit in writing its inability to pay its debts generally as they mature; (2) make an assignment for the
benefit of creditors or commence proceedings for its dissolution; or (3) apply for or consent to the appointment of a trustee,
liquidator or receiver for its or for a substantial part of its property or business (as to which no cure period shall apply);
or

 

    	 	7	 

     

    

 

g.
A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without
its consent and shall not be discharged within sixty (60) days after such appointment (as to which no cure period shall apply);
or

 

h.
Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody
or control of the whole or any substantial portion of the properties or assets of the Company and shall not be dismissed within
sixty (60) days thereafter (as to which no cure period shall apply); or

 

i.
Any money judgment, writ or warrant of attachment, or similar process (including an arbitral determination), in excess of Fifty
Thousand Dollars ($50,000) in the aggregate shall be entered or filed against the Company or any of its properties or other assets
(as to which no cure period shall apply); or

 

j.
The occurrence of a breach or an event of default under the terms of any indebtedness or financial instrument of the Company or
any subsidiary (including but not limited to any Subsidiary) of the Company in an aggregate amount in excess of Fifty Thousand
Dollars ($50,000) or more which is not waived by the creditors under such indebtedness (as to which no cure period shall apply);
or

 

k.
Bankruptcy, reorganization, insolvency or liquidation proceedings or other proceedings for relief under any bankruptcy law or
any law for the relief of debtors shall be instituted by or against the Company and, if instituted against the Company, shall
not be dismissed within sixty (60) days after such institution or the Company shall by any action or answer approve of, consent
to, or acquiesce in any such proceedings or admit the material allegations of, or default in answering a petition filed in any
such proceeding (as to which no further cure period shall apply); or

 

l.
The issuance of an order, ruling, finding or similar adverse determination the SEC, the Secretary of State of the State of Nevada
or other applicable state of incorporatin of the Company, the National Association of Securities Dealers, Inc. or any other securities
regulatory body (whether in the United States, Canada or elsewhere) having proper jurisdiction that the Company and/or any of
its past or present directors or officers have committed a material violation of applicable securities laws or regulations (as
to which no cure period shall apply); or

 

m.
The Company shall have its Common Stock suspended or delisted from a national securities exchange or an electronic quotation service
such as the OTCP, OTCQB, or OTCQX for a period in excess of five (5) Trading Days (as to which no further cure period shall apply);
or

 

n.
Any of the following shall occur and be continuing: a breach or default by any party under (a) any agreement identified by the
Company in its SEC filings as a material agreement or (b) any note or other form of indebtedness in favor of the Company representing
indebtedness of at least Fifty Thousand Dollars ($50,000.00), irrespective of whether such breach or default was waived (as to
which no cure period shall apply); or

 

    	 	8	 

     

    

 

o.
Notice of a Material Adverse Effect is provided by the Company or the determination in good faith by the Holder that a Material
Adverse Effect has occurred (as to which no cure period shall apply); or

 

p.
The Company attempts to modify, amend, withdraw, rescind, disavow or repudiate any part of the Irrevocable Instructions (as to
which no cure period shall apply).

 

q.
Any attempt by the Company or its officers, directors, and/or affiliates to transmit, convey, disclose, or any actual transmittal,
conveyance, or disclosure by the Company or its officers, directors, and/or affiliates of, material non-public information concerning
the Company, to the Holder or its successors and assigns, which is not immediately cured by Company’s filing of a Form 8-K
pursuant to Regulation FD on that same date.

 

r.
At any time while this Debenture is outstanding, the lowest traded price on the OTCP, OTCQB, or OTCQX, or other applicable principal
trading market for the Common Stock, is equal to or less than $0.0001.

 

Then,
or at any time thereafter, the Company shall immediately give written notice of the occurrence of such Event of Default to
the Holders of all Debentures then outstanding, and in each and every such case, unless such Event of Default shall have been
waived in writing by a majority in interest of the Holders of the Debentures (which waiver shall not be deemed to be a waiver
of any subsequent default), then at the option of a majority in interest of the Holders and in the discretion of a majority
in interest of the Holders, take any or all of the following actions: (i) pursue remedies against the Company in accordance
with any of the Holder’s rights, (ii) increase the interest rate applicable to the Debentures to the lesser of eighteen
percent (18%) per annum and the maximum interest rate allowable under applicable law, (iii) in the case of an Event of
Default under Section 10(e)(ii)(1) based on the Company’s failure to be DWAC Operational, increase the Principal Amount
to an amount equal to one hundred ten percent (110%) of the then-outstanding Principal Amount, (iv) in the case of an Event
of Default under Section 10(d)(i), increase the Principal Amount to an amount equal to one hundred twenty percent (120%) of
the then-outstanding Principal Amount and an additional ten percent (10%) discount shall be factored into the Conversion
Price until this Debenture is no longer outstanding, (v) in the case of an Event of Default under Section 10(d)(i) through
(v), increase the Principal Amount of the relevant Holder’s Debenture by One Thousand Dollars and 00/100 ($1,000.00)
for each day the related failure continues, (vi) in the case of an Event of Default under Section 10(d)(ii) through (v)
arising from an untimely delivery to the Holder of Conversion Shares or shares of Common Stock in de-legended form, if the
lowest traded price of the Common Stock on the Trading Day immediately prior to the actual date of delivery of Conversion
Shares or de-legended shares, as the case may be, is less than the lowest traded price on the Trading Day immediately prior
to the date when Conversion Shares or de-legended shares were required to be delivered, increase the Principal Amount of the
relevant Holder’s Debenture by an amount per share equal to such difference, and (vii) following the expiration of the
applicable grace period (if any), at the option and discretion of the Holder, accelerate the full indebtedness under
this Debenture, in an amount equal to one hundred forty percent (140%) of the outstanding Principal Amount and accrued and
unpaid interest (the “Acceleration Amount”), whereupon the Acceleration Amount shall be immediately due and
payable, without presentment, demand, protest or notice of any kinds, all of which are hereby expressly waived, anything
contained herein, in the Securities Purchase Agreement or in any other note or instruments to the contrary notwithstanding.
In the case of an Event of Default under Section 10(d)(ii), the Holder may either (i) declare the Acceleration Amount to
exclude the Conversion Amount that is the subject of the Event of Default, in which case the Acceleration Amount shall be
based on the remaining Principal Amount and accrued interest (if any), in which case the Company shall continue to be
obligated to issue the Conversion Shares, or (ii) declare the Acceleration Amount to include the Conversion Amount that is
the subject of the Event of Default, in which case the Acceleration Amount shall be based on the full Principal Amount,
including the Conversion Amount, and accrued interest (if any), whereupon the Notice of Conversion shall be deemed withdrawn.
At its option, the Holder may elect to convert the Debenture pursuant to Section 2 notwithstanding the prior declaration of a
default and acceleration, in the sole discretion of such Holder. A majority in interest of the Holders may immediately
enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by
applicable law. Notwithstanding the foregoing, in the case of a default under Section 10(d)(ii) through (iv), the Holder
of the Debenture sought to be converted, transferred or de-legended, as the case may be, acting singly, shall have the sole
and absolute discretion to increase the applicable interest rate on the Debentures held by such Holder and/or to accelerate
the Debenture(s) held by such Holder. The Company expressly acknowledges and agrees that the Holder’s exercise of any
or all of the remedies provided herein or under applicable law, including without limitation the increase(s) in the Principal
Amount and the Acceleration Amount as may be declared in the case of a default, is reasonable and appropriate due to the
inability to define the financial hardship that the Company’s default would impose on the Holders. To the extent that
the Holder’s exercise of any of its remedies in the case of an Event of Default shall be construed to exceed the
maximum interest rate allowable under applicable law, then such remedies shall be reduced to equal the maximum interest rate
allowable under applicable law.

 

    	 	9	 

     

    

 

11.
Nothing contained in this Debenture shall be construed as conferring upon the Holder the right to vote or to receive dividends
or to consent or receive notice as a shareholder in respect of any meeting of shareholders or any rights whatsoever as a shareholder
of the Company, unless and to the extent converted in accordance with the terms hereof.

 

12.
So long as this Debenture is outstanding, upon any issuance by the Company or any of its subsidiaries of any security with any
term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly
provided to the Holder in this Debenture, then the Company shall notify the Holder of such additional or more favorable term and
such term, at Holder’s option, shall become a part of the transaction documents with the Holder. The types of terms contained
in another security that may be more favorable to the holder of such security include, but are not limited to, terms addressing
conversion discounts, prepayment rate, conversion lookback periods, interest rates, original issue discounts, stock sale price,
private placement price per share, and warrant coverage.

 

13.
This Debenture may be amended only by the written consent of the parties hereto. Notwithstanding the foregoing, the Principal
Amount of this Debenture shall automatically be reduced by any and all Conversion Amounts (to the extent that the same relate
to principal hereof). In the absence of manifest error, the outstanding Principal Amount of the Debenture on the Holder’s
book and records shall be the correct amount.

 

14.
In the event of any inconsistency between the provisions of this Debenture and the provisions of any other Transaction Document,
the provisions of this Debenture shall prevail. Without limiting the generality of the foregoing, in the event the Transfer Agent
is not required to transfer any Common Stock, issue Conversion Shares or de-legended shares of Restricted Stock pursuant to the
Transfer Agent Instruction Letter, this shall not operate as an excuse, extension or waiver of the Company’s obligation
to issue and deliver Conversion Shares or delegended Restricted Stock.

 

15.
The Company specifically acknowledges and agrees that in the event of a breach or threatened breach by the Company of any provision
hereof or of any other Transaction Document, the Holder will be irreparably damaged, and that damages at law would be an inadequate
remedy if this Debenture or such other Transaction Document were not specifically enforced. Therefore, in the event of a breach
or threatened breach by the Company, the Holder shall be entitled, in addition to all other rights and remedies, to an injunction
restraining such breach, without being required to show any actual damage or to post any bond or other security, and/or to a decree
for a specific performance of the provisions of this Debenture and the other Transaction Documents.

 

16.
No waivers or consents in regard to any provision of this Debenture may be given other than by an instrument in writing signed
by the Holder.

 

    	 	10	 

     

    

 

17.
Each time, while this Debenture is outstanding, the Company enters into a Section 3(a)(9) transaction (including but not limited
to the issuance of new promissory notes or debentures, or of a replacement promissory note or debenture), or Section 3(a)(10)
transaction, in which any 3rd party has the right to convert monies owed to that 3rd party (or receive shares pursuant to a settlement
or otherwise) at a discount to market greater than the Conversion Price in effect at that time (prior to all other applicable
adjustments in this Debenture), then the Conversion Price shall be automatically adjusted to such greater discount percentage
(prior to all applicable adjustments in this Debenture) until this Debenture is no longer outstanding. Each time, while this Debenture
is outstanding, the Company enters into a Section 3(a)(9) transaction (including but not limited to the issuance of new promissory
notes or debentures, or of a replacement promissory note or debenture), or Section 3(a)(10) transaction, in which any 3rd party
has a look back period greater than the look back period in effect under this Debenture at that time, then the Holder’s
look back period shall automatically be adjusted to such greater number of days until this Debenture is no longer outstanding.
The Company shall give written notice to the Holder, with the adjusted Conversion Price and/or adjusted look back period (each
adjustment that is applicable due to the triggering event), within one (1) business day of an event that requires any adjustment
described in this section. So long as this Note is outstanding, the Company shall not enter into any transaction or arrangement
structured in accordance with, based upon, or related or pursuant to, in whole or in part, either Section 3(a)(9) of the Securities
Act (a “3(a)(9) Transaction”) or Section 3(a)(l0) of the Securities Act (a “3(a)(l0) Transaction”). In
the event that the Company does enter into, or makes any issuance of Common Stock related to a 3(a)(9) Transaction or a 3(a)(l0)
Transaction while this note is outstanding, a liquidated damages charge of 20% of the outstanding principal balance of this Note,
but not less than Fifteen Thousand Dollars $15,000, will be assessed and will become immediately due and payable to the Holder
at its election in the form of cash payment or addition to the balance of this Note.

 

18.
So long as this Debenture is outstanding, upon any issuance by the Company or any of its subsidiaries of any security with any
term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly
provided to the Holder in this Debenture, then the Company shall notify the Holder of such additional or more favorable term and
such term, at Holder’s option, shall become a part of the transaction documents with the Holder (regardless of whether the
Company notifies the Holder or not). The types of terms contained in another security that may be more favorable to the holder
of such security include, but are not limited to, terms addressing conversion discounts, prepayment rate, conversion lookback
periods, interest rates, original issue discounts, stock sale price, private placement price per share, and warrant coverage.

 

[Signature
Page Follows]

 

    	 	11	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Debenture to be duly executed by an officer thereunto duly authorized as of the
date of issuance set forth above.

 

	 	NANOFLEX
    POWER CORPORATION
	 	 	 
	 	By:	/s/
    Dean Ledger
	 	Name:	Dean
    Ledger
	 	Title:	Chief
    Executive Officer

 

[Signature
Page to Convertible Debenture]

 

    	 	12	 

     

    

 

ANNEX
A 

 

NANOFLEX
POWER CORPORATION

 

NOTICE
OF CONVERSION 

 

(To
Be Executed by the Registered Holder in Order to Convert the Debenture)

 

The
undersigned hereby irrevocably elects to convert $ of the Principal Amount of the above Debenture into Shares of Common
Stock of NanoFlex Power Corporation, a Florida corporation (the “Company”), according to the conditions hereof,
as of the date written below. After giving effect to the conversion requested hereby, the outstanding Principal Amount of
such debenture is $ , absent manifest error.

 

Pursuant
to the Debenture, certificates representing Common Stock upon conversion must be delivered (including delivery by DWAC or DRS)
to the undersigned within two (2) business days from the date of delivery of the Notice of Conversion to the Transfer Agent.

 

Conversion
Date

  

 

Applicable
Conversion Price

 

 

Signature

 

 

Print
Name

 

 

Address

 

 

 

    	 	13Exhibit 4.8

 

NEITHER
THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

NANOFLEX
POWER CORPORATION

 

Warrant
Shares: 200,000

Date
of Issuance: June 13, 2018 (“Issuance Date”)

 

This
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance
of the $75,000.00 convertible debenture to Peak One Opportunity Fund, L.P., a Delaware limited partnership (the “Fund”)
on or around June 13, 2018 (the “Debenture”), Peak One Investments, LLC, a Delaware limited liability company
(including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to
the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to
purchase from NanoFlex Power Corporation, a Florida corporation (the “Company”), up to 200,000 shares of Common
Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant
to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company
as of the date hereof in connection with that certain securities purchase agreement dated June 13, 2018, by and among the Company
and the Fund (the “Purchase Agreement”).

 

Capitalized
terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of
this Warrant or in Section 12 below. For purposes of this Warrant, the term “Exercise Price” shall mean $0.10,
subject to adjustment as provided herein (including but not limited to cashless exercise), and the term “Exercise Period”
shall mean the period commencing on the Issuance Date and ending on 5:00 p.m. eastern standard time on the three-year anniversary
thereof.

 

1. EXERCISE
OF WARRANT.

 

(a) Mechanics
of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto
as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The
Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of
this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the
effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. On or before the third Trading Day (the “Warrant Share Delivery Date”)
following the date on which the Company shall have received the Exercise Notice, and upon receipt by the Company of payment
to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which all
or a portion of this Warrant is being exercised (the “Aggregate Exercise Price” and together with the
Exercise Notice, the “Exercise Delivery Documents”) in cash or by wire transfer of immediately available
funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided), the Company shall (or
direct its transfer agent to) issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a
certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of
shares of Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Delivery
Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing
such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant
Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an
exercise, then the Company shall as soon as practicable and in no event later than three Business Days after any exercise and
at its own expense, issue a new Warrant (in accordance with Section 6) representing the right to purchase the number of
Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with
respect to which this Warrant is exercised.

 

     

     

    

 

If
the Company fails to cause its transfer agent to transmit to the Holder the respective shares of Common Stock by the respective
Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion, and
such failure shall be deemed an event of default under the Debenture.

 

If
the Market Price of one share of Common Stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares
pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described
below (or of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which event
the Company shall issue to Holder a number of Common Stock computed using the following formula:

 

X
= Y (A-B)

 

   A

 

Where
X =        the number of Shares to be issued to Holder.

 

            Y
=        the number of Warrant Shares that the Holder elects to purchase under this Warrant

                          (at
the date of such calculation).

 

            A
=        the Market Price (at the date of such calculation).

 

            B
=        Exercise Price (as adjusted to the date of such calculation).

 

(b) No
Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes
of determining whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise
would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder
otherwise entitled to such fraction a sum in cash equal to the product resulting from multiplying the then-current fair market
value of a Warrant Share by such fraction.

 

(c) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, to the extent that after giving effect to issuance of Warrant Shares upon exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess
of the Beneficial Ownership Limitation, as defined below. For purposes of the foregoing sentence, the number of shares of
Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable
upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares
of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or non-converted
portion of any other securities of the Company (including without limitation any other Common Stock Equivalents) subject to a
limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of
its Affiliates. Except as set forth in the preceding sentence, for purposes of this paragraph (d), beneficial ownership shall
be calculated in accordance with Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is
not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this paragraph applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any affiliates) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination.

 

    	 	2	 

     

    

 

For
purposes of this paragraph, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the
Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the
Company or its transfer agent setting forth the number of shares of Common Stock outstanding. Upon the request of a Holder, the
Company shall within two Trading Days confirm to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. Upon no fewer than 61 days’ prior notice to the Company, a Holder may increase or decrease the
Beneficial Ownership Limitation provisions of this paragraph, provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock upon exercise of this Warrant held by the Holder and the provisions of this paragraph shall continue to apply. Any such
increase or decrease will not be effective until the 61st day after such notice is delivered to the Company and shall only apply
to such Holder and no other Holder. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant.

 

2. ADJUSTMENTS.
The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a) Distribution
of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation any
distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement or other similar transaction) (a “Distribution”), at any time after the issuance
of this Warrant, then, in each such case:

 

(i) any
Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders
of shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such
record date, to a price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing
Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution
(as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the
denominator of which shall be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such
record date; and

 

    	 	3	 

     

    

 

(ii) the
number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately
prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to
receive the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided,
however, that in the event that the Distribution is of shares of common stock of a company (other than the Company) whose common
stock is traded on a national securities exchange or a national automated quotation system (“Other Shares of Common Stock”),
then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of
Warrant Shares, the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable
into the number of shares of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution
had the Holder exercised this Warrant immediately prior to such record date and with an aggregate exercise price equal to the
product of the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the
terms of the immediately preceding clause (i) and the number of Warrant Shares calculated in accordance with the first part of
this clause (ii).

 

3. FUNDAMENTAL
TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company with or
into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii)
any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is
completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other
securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iv) the Company effects
any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of
Common Stock) (in any such case, a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive the number of shares of Common Stock of the Successor Entity or of the Company and
any additional consideration (the “Alternate Consideration”) receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a holder of the number of shares of Common Stock for which
this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise contained herein solely for
the purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of
Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the
Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental
Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s
right to exercise such warrant into Alternate Consideration.

 

4. NON-CIRCUMVENTION.
The Company covenants and agrees that it will not, by amendment of its certificate of incorporation, bylaws or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good
faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.
Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common
Stock upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved,
free from preemptive rights, ten (10) times the number of shares of Common Stock into which the Warrants are then exercisable
into to provide for the exercise of the rights represented by this Warrant (without regard to any limitations on exercise).

 

5. WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall
not entitle the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of
this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by
creditors of the Company.

 

    	 	4	 

     

    

 

6.REISSUANCE.

 

(a) Lost,
Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as to
indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

 

(b) Issuance
of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which
is the same as the Issuance Date.

 

7.TRANSFER.

 

(a) Notice
of Transfer. The Holder agrees to give written notice to the Company before transferring this Warrant or transferring any
Warrant Shares of such Holder’s intention to do so, describing briefly the manner of any proposed transfer. Promptly upon
receiving such written notice, the Company shall present copies thereof to the Company’s counsel. If the proposed transfer
may be effected without registration or qualification (under any federal or state securities laws), the Company, as promptly as
practicable, shall notify the Holder thereof, whereupon the Holder shall be entitled to transfer this Warrant or to dispose of
Warrant Shares received upon the previous exercise of this Warrant, all in accordance with the terms of the notice delivered by
the Holder to the Company; provided, however, that an appropriate legend may be endorsed on this Warrant or the certificates for
such Warrant Shares respecting restrictions upon transfer thereof necessary or advisable in the opinion of counsel and satisfactory
to the Company to prevent further transfers which would be in violation of Section 5 of the Securities Act and applicable state
securities laws; and provided further that the prospective transferee or purchaser shall execute the Assignment of Warrant attached
hereto as Exhibit B and such other documents and make such representations, warranties, and agreements as may be required
solely to comply with the exemptions relied upon by the Company for the transfer or disposition of the Warrant or Warrant Shares.

 

(b) If
the proposed transfer or disposition of this Warrant or such Warrant Shares described in the written notice given pursuant to
this Section 7 may not be effected without registration or qualification of this Warrant or such Warrant Shares, the Holder will
limit its activities in respect to such transfer or disposition as are permitted by law.

 

(c) Any
transferee of all or a portion of this Warrant shall succeed to the rights and benefits of the initial Holder of this Warrant.

 

8.NOTICES.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written notice
(i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment
and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend
or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any stock or other securities
directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata
to the holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution
or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with
such notice being provided to the Holder.

 

9.AMENDMENT
AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either retroactively
or prospectively) only with the written consent of the Company and the Holder.

 

    	 	5	 

     

    

 

10. GOVERNING
LAW. This Warrant shall be governed by and construed in accordance with the laws of the State of Nevada without regard to
principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Warrant shall be brought only in the state courts or federal courts located in the State of Florida, County of Miami-Dade.
The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder
and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. EACH PARTY
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT ENTERED INTO IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER
TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. The prevailing party shall be entitled to recover
from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Warrant or any other agreement
delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute
or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability
of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process
being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other
manner permitted by law.

 

11. ACCEPTANCE.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained
herein.

 

12. CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Nasdaq”
means www.Nasdaq.com.

 

(b) “Closing
Sale Price” means, for any security as of any date, (i) the last closing trade price for such security on the Principal
Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq,
or (ii) if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security
as reported by Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid and ask
prices of any market makers for such security as reported by the OTC Markets. If the Closing Sale Price cannot be calculated for
a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the
fair market value as mutually determined by the Company and the Holder. All such determinations to be appropriately adjusted for
any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

(c) “Common
Stock” means the Company’s common stock, and any other class of securities into which such securities may hereafter
be reclassified or changed.

 

(d) “Common
Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at any time
Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that is at
any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

(e) “Dilutive
Issuance” is any issuance of Common Stock or Common Stock Equivalents described in Section 2(b) above; provided, however,
that a Dilutive Issuance shall not include any Exempt Issuance.

 

    	 	6	 

     

    

 

(f) “Exempt
Issuance” means the issuance of (i) shares of Common Stock or options to officers or directors of the Company pursuant
to any stock or option plan duly adopted by a majority of the non-employee members of the Board of Directors of the Company or
a majority of the members of a committee of non-employee directors established for such purpose, (ii) securities issued pursuant
to acquisitions approved by a majority of the disinterested directors of the Company, and (iii) shares of Common Stock issued
pursuant to any real property leasing arrangement or financing from a national bank approved by the Board of Directors of the
Company.

 

(g) “Principal
Market” means the primary national securities exchange on which the Common Stock is then traded.

 

(h) “Market
Price” means the highest traded price of the Common Stock during the thirty Trading Days prior to the date of the respective
Exercise Notice.

 

(i) “Trading
Day” means (i) any day on which the Common Stock is listed or quoted and traded on its Principal Market, (ii) if the
Common Stock is not then listed or quoted and traded on any national securities exchange, then a day on which trading occurs on
any over-the-counter markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.

 

*
* * * * * *

 

    	 	7	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

 

	 	NANOFLEX POWER CORPORATION
	 	 	 
	 	 	/s/ Dean Ledger
	 	Name:	Dean Ledger
	 	Title: 	Chief Executive Officer

 

     

     

    

 

EXHIBIT
A

 

EXERCISE
NOTICE

 

(To
be executed by the registered holder to exercise this Common Stock Purchase Warrant)

 

The
Undersigned holder hereby exercises the
right to purchase _______________________ of the shares of Common Stock (“Warrant Shares”) of NanoFlex Power
Corporation, a Florida corporation (the “Company”), evidenced by the attached copy of the Common Stock Purchase
Warrant (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective
meanings set forth in the Warrant.

 

		1.	Form
                                         of Exercise Price. The Holder intends that payment of the Exercise Price shall be
                                         made as (check one):

 

☐
a cash exercise with respect to_________________Warrant Shares; or

☐
by cashless exercise pursuant to the Warrant.

 

		2.	Payment
                                         of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable
                                         Aggregate Exercise
Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.

 

		3.	Delivery
                                         of Warrant Shares. The Company shall deliver to the holder______________________ Warrant
                                         Shares in accordance with the terms of the Warrant.

 

Date:
____________________________

 

	 	 	 
	 	(Print Name of Registered Holder)
	 	 
	 	By: 	 
	 	Name:	 
	 	Title:	 

 

     

     

    

 

EXHIBIT
B

 

ASSIGNMENT
OF WARRANT

 

(To
be signed only upon authorized transfer of the Warrant)

 

For
Value Received, the undersigned hereby sells,
assigns, and transfers unto______________________the right to purchase ___________________ shares of common stock of NanoFlex
Power Corporation, to which the within Common Stock Purchase Warrant relates and appoints _______________________, as attorney-in-fact,
to transfer said right on the books of NanoFlex Power Corporation with full power of substitution and re-substitution in the premises.
By accepting such transfer, the transferee has agreed to be bound in all respects by the terms and conditions of the within Warrant.

 

Dated: ___________________

 

	 	 
	 	(Signature) *
	 	 
	 	 
	 	(Name)
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Social Security or Tax Identification No.)

 

*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase
Warrant in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation,
partnership, trust or other entity, please indicate your position(s) and title(s) with such entity.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]